Table 1 Clinical characteristics of three groups

Age (years)

58.1 ± 19.9

59.3 ± 17.9

57.9 ± 14.3

0.141

Male, n (%)

55(65)

20(65)

22(71)

0.317

Body-mass index (kg/ m²)

26.2 ± 4.5

26.0 ± 5.5

24.2 ± 3.5

0.083

Time in predialytic ERSD (mo)

–

70(1–148)

73(1–216)

0.351

Cumulative time on dialysis (mo)

–

24(1–94)

26(1–104)

0.561

Hypertension, n (%)

11(12)

28(90)^†

25(80)^†

0.039

Diabetes mellitus, n (%)

11(13)

9(28)^†

8(27)^†

0.025

Dyslipidemia, n (%)

4 (5)

2(6)

2(6)

0.676

Smokers, n

4

3

1

0.07

Systolic blood pressure (mmHg)

119.3 ± 15.8

146.9 ± 21.3^†

145.8 ± 13.5^†

<0.001

Diastolic blood pressure (mmHg)

77.1 ± 8.3

86.9 ± 13.5^†

94.3 ± 8.6^†‡

<0.001

Glycosylated hemoglobin A1c (%)

4.6 ± 0.7

4.7 ± 0.7

4.9 ± 0.6

0.156

Total cholesterol (m mol / L)

6.0 ± 1.2

4.9 ± 1.2

4.5 ± 0.8

0.322

Triglycerides (m mol / L)

1.4 ± 0.7

1.9 ± 0.9

1.4 ± 0.3

0.345

Low-density lipoprotein (m mol / L)

3.1 ± 0.9

2.7 ± 0.9

2.3 ± 0.6

0.224

High-density lipoprotein (m mol / L)

1.2 ± 0.3

1.3 ± 0.3

1.4 ± 0.3

0.432

Fasting glucose (m mol / L)

5.3 ± 1.1

4.6 ± 0.6

4.9 ± 0.7

0.245

Ca (m mol / L)

2.39 ± 0.10

2.40 ± 0.14

2.33 ± 0.19

0.422

P (m mol / L)

1.33 ± 0.12

1.79 ± 0.24†

1.39 ± 0.56^#

0.003

PTH (pg/ml)

35 ± 26

27 ± 20†

39 ± 22^#

0.050

ACEI use, n (%)

5(6)

17(56)^†

20(64)^†

0.038

Calcium channel antagonist, n (%)

4(5)

16(50)^†

10(32)^†

0.032

Diuretics, n (%)

4(5)

12(40)^†

6(18)^†#

0.042

Beta-blockers, n (%)

4(5)

12(40)^†

8(25)^†#

0.036

Statin use, n (%)

15(18)

11(35)^†

10(33)^†

0.046